Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
已完结10由 adobetime 发布于 2026/2/19 23:47:43
DOI:10.1016/s2213-2600(25)00258-9
作者:Jia Zhong, Jun Zhao, Jianchun Duan, Jian Fang, Kailun Fei, Xiaoyan Li, Jiayan Chen, Zhijie Wang, Qian Chu, Yan Yu, Zhe Liu, Li Zhang, Yanqiu Zhao, Xingya Li, Lin Wu, Ligang Xing, Wu Zhuang, Xuefeng Fa
文献类型:期刊论文
补充材料:只需要正文